Skyhawk Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Skyhawk Therapeutics's estimated annual revenue is currently $5.5M per year.
- Skyhawk Therapeutics's estimated revenue per employee is $77,500
- Skyhawk Therapeutics's total funding is $181.2M.
Employee Data
- Skyhawk Therapeutics has 71 Employees.
- Skyhawk Therapeutics grew their employee count by -94% last year.
Skyhawk Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, CEO & Chairman | Reveal Email/Phone |
2 | SVP Chemistry | Reveal Email/Phone |
3 | SVP, Nonclinical Development | Reveal Email/Phone |
4 | Head Business Development | Reveal Email/Phone |
5 | VP Legal | Reveal Email/Phone |
6 | SVP, Discovery Biology | Reveal Email/Phone |
7 | Director, Medicinal Chemistry | Reveal Email/Phone |
8 | Director Chemistry | Reveal Email/Phone |
9 | VP, Director Molecular Therapeutics | Reveal Email/Phone |
10 | Associate Director, Bioinformatics | Reveal Email/Phone |
Skyhawk Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Skyhawk Therapeutics?
Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted towards cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.
keywords:N/A
$181.2M
Total Funding
71
Number of Employees
$5.5M
Revenue (est)
-94%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Skyhawk Therapeutics News
... H3 Biomedicine Inc., Novartis AG, PTC Therapeutics, Ribometrix, SERVIER LABORATORIES, Skyhawk Therapeutics, , Other Market Participants.
Skyhawk Therapeutics, Inc., a Cambridge, Mass.-based drug development company, closed a new $40m equity investment round alongside its recently announced $60m strategic collaboration. This brings total new capital into the company to over $100m. Participants in the all-common stock equity round ...
Skyhawk Therapeutics, Inc., today announced the closing of a new $40 million equity investment round alongside its recently announced $60 million strategic collaboration, bringing total new capital into the company to over $100 million. Proceeds will be used for development of Skyhawk's innovati ...
Skyhawk Therapeutics, Inc., a Waltham, Mass.-based company focused on the discovery and development of small molecule therapeutics that correct RNA expression, closed $8m seed funding round. The round was led by major family and biotech investors, including Tim Disney, the Duke of Bedford, Alex ...
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.3M | 71 | 13% | $1.7M |
#2 | $21.7M | 73 | -28% | N/A |
#3 | $11.3M | 73 | 11% | N/A |
#4 | $3.5M | 74 | -4% | N/A |
#5 | $11.5M | 74 | 19% | N/A |